fig4

Overcoming immuno-resistance by rescheduling anti-VEGF/cytotoxics/anti-PD-1 combination in lung cancer model

Figure 4. Simulation of individual growth tumor by treatment compared with control. (A) Anti-PD1; (B) Anti-VEGF + CT; (C) Concurrent Protocol; (D) Reverse Protocol; (E) Test Protocol.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/